Withdrawal of Registration Statement (rw)
January 24 2018 - 5:05PM
Edgar (US Regulatory)
RICH
PHARMACEUTICALS, INC.
9595
Wilshire Blvd, Suite 900
Beverly
Hills, CA 90212
January
24, 2018
SECURITIES
AND EXCHANGE COMMISSION
100
F. Street NE
Washington,
D.C. 20549
Re:
|
|
Rich
Pharmaceuticals, Inc.
Registration
Statement on Form S-1
File
No. 333-217307
Application
for Withdrawal
|
Ladies
and Gentlemen:
Pursuant
to Rule 477 under the Securities Act of 1933, as amended, Rich Pharmaceuticals, Inc. (the “Company”) hereby requests
the immediate withdrawal of its registration statement on Form S-1 (File No. 333-217307), filed on April 14, 2017, together with
all exhibits thereto (collectively, the “Registration Statement”).
No
shares were sold in connection with the offering. The Company requests the withdrawal of such Registration Statement because it
completed a reverse stock split after the effectiveness of the Registration Statement and it would no longer be economically feasible
to sell the small number of shares registered in the Registration Statement.
Should
you have any questions regarding the Company’s application for withdrawal of the Registration Statement, please contact
legal counsel to the Company, Steven J. Davis, SD Law Group, APC, 10531 4S Commons Drive, B464, San Diego, California 92127. Kindly
forward a copy of the order withdrawing the Registration Statement to the attention of Mr. Davis at the address set forth above.
Sincerely,
Rich
Pharmaceuticals, Inc.
By:
/s/
Ben Chang
Ben
Chang
Chief
Executive Officer